Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
19.56
-0.04 (-0.20%)
At close: Oct 23, 2026, 4:00 PM EDT
19.74
+0.18 (0.92%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, Sabra Health Care REIT stock has a consensus rating of "Buy" and an average price target of $22.36. The average 1-year stock price forecast is 14.31% higher than the current stock price, while the lowest is $19 (-2.86%) and the highest is $25 (+27.81%).
Price Target: $22.36 (+14.31%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 7 | 9 | 9 | 10 | 10 | 10 |
| Sell | 0 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 15 | 16 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +7.36% | Oct 19, 2026 |
| UBS | UBS | Hold Reiterates $21 → $20 | Hold | Reiterates | $21 → $20 | +2.25% | Oct 13, 2026 |
| Barclays | Barclays | Hold Maintains $23 → $21 | Hold | Maintains | $23 → $21 | +7.36% | Oct 13, 2026 |
| Janney Montgomery | Janney Montgomery | Buy Initiates $23 | Buy | Initiates | $23 | +17.59% | Sep 9, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | +7.36% | Aug 31, 2026 |
Financial Forecast
Revenue This Year
926.51M
from 775.76M
Increased by 19.43%
Revenue Next Year
1.02B
from 926.51M
Increased by 10.46%
EPS This Year
0.67
EPS Next Year
0.81
from 0.67
Increased by 20.90%
EPS based on non-GAAP adjusted numbers.